October 27, 2020 Project deliverable Open Access

Miceli, Rosalba

JSON Export

{
  "files": [
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2001%20-%20Informed%20consent%20and%20screening.pdf"
      }, 
      "checksum": "md5:9e76ba9ce7449946208ed3671708681a", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 01 - Informed consent and screening.pdf", 
      "type": "pdf", 
      "size": 300240
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2002%20-%20Registration%20and%20baseline.pdf"
      }, 
      "checksum": "md5:7b8e59a29dddc2557b2feb0f4d4ccf34", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 02 - Registration and baseline.pdf", 
      "type": "pdf", 
      "size": 437022
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2003%20-%20Immune-Related%20Adverse%20Event%20Log.pdf"
      }, 
      "checksum": "md5:8cf9aff5eb0f7a9c73c7e5e1a7bcd69e", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 03 - Immune-Related Adverse Event Log.pdf", 
      "type": "pdf", 
      "size": 418289
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2004%20-%20Lab%20tests%20and%20concomitant%20medications.pdf"
      }, 
      "checksum": "md5:56ce54905fd27cc86f41c3ccb1abc962", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 04 - Lab tests and concomitant medications.pdf", 
      "type": "pdf", 
      "size": 351145
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2005%20-%20Questionnaires%20distress%20and%20health.pdf"
      }, 
      "checksum": "md5:7f636af6fb4cb5fe0b47abffc9e73df8", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 05 - Questionnaires distress and health.pdf", 
      "type": "pdf", 
      "size": 420659
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2006%20-%20Follow%20up%20log.pdf"
      }, 
      "checksum": "md5:8426e929b3fe4c2431c771205358296b", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 06 - Follow up log.pdf", 
      "type": "pdf", 
      "size": 275313
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2007%20-%20Study%20specific%20blood%20and%20stool%20samples.pdf"
      }, 
      "checksum": "md5:03b3365f6c069fd533cfe3aa48dac685", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 07 - Study specific blood and stool samples.pdf", 
      "type": "pdf", 
      "size": 404464
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2008%20-%20Off%20study.pdf"
      }, 
      "checksum": "md5:21572912f11bf38100820705013031f7", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 08 - Off study.pdf", 
      "type": "pdf", 
      "size": 249652
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2009%20-%20ICI%20and%20oncologic%20treatments%20log.pdf"
      }, 
      "checksum": "md5:c4b78ec52bf59623a905668fd7123aeb", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 09 - ICI and oncologic treatments log.pdf", 
      "type": "pdf", 
      "size": 218669
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2010%20-%20Diet%20form.pdf"
      }, 
      "checksum": "md5:ef437dbafe94e3c92f0887dc8fdbd23c", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 10 - Diet form.pdf", 
      "type": "pdf", 
      "size": 276258
    }, 
    {
      "links": {
        "self": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8/CRF%2011%20-%20Pre-Screening%20form.pdf"
      }, 
      "checksum": "md5:a703c29a00c1ef6bb162c70d95f8998d", 
      "bucket": "0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
      "key": "CRF 11 - Pre-Screening form.pdf", 
      "type": "pdf", 
      "size": 223341
    }
  ], 
  "owners": [
    148918
  ], 
  "doi": "10.5281/zenodo.4142787", 
  "stats": {
    "version_unique_downloads": 88.0, 
    "unique_views": 79.0, 
    "views": 104.0, 
    "version_views": 104.0, 
    "unique_downloads": 88.0, 
    "version_unique_views": 79.0, 
    "volume": 34636104.0, 
    "version_downloads": 110.0, 
    "downloads": 110.0, 
    "version_volume": 34636104.0
  }, 
  "links": {
    "doi": "https://doi.org/10.5281/zenodo.4142787", 
    "conceptdoi": "https://doi.org/10.5281/zenodo.4142786", 
    "bucket": "https://zenodo.org/api/files/0b953c36-aa06-40fc-a8f6-d422922cd2c8", 
    "conceptbadge": "https://zenodo.org/badge/doi/10.5281/zenodo.4142786.svg", 
    "html": "https://zenodo.org/record/4142787", 
    "latest_html": "https://zenodo.org/record/4142787", 
    "badge": "https://zenodo.org/badge/doi/10.5281/zenodo.4142787.svg", 
    "latest": "https://zenodo.org/api/records/4142787"
  }, 
  "conceptdoi": "10.5281/zenodo.4142786", 
  "created": "2020-10-27T21:24:36.050008+00:00", 
  "updated": "2020-10-29T00:26:57.377553+00:00", 
  "conceptrecid": "4142786", 
  "revision": 4, 
  "id": 4142787, 
  "metadata": {
    "access_right_category": "success", 
    "doi": "10.5281/zenodo.4142787", 
    "description": "<p><strong><a href=\"https://gdefiner.net/\">https://gdefiner.net/</a> </strong></p>\n\n<p><strong>Project: &quot;Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment&quot; </strong></p>\n\n<p><strong>(G-DEFINER). </strong></p>\n\n<p><strong>Clinical study CRFs. (DOI of the Study Protocol: 10.5281/zenodo.4142124)</strong></p>\n\n<p>This is a multicenter observational prospective clinical study aimed at investigating the inequalities between female (F) and male (M) patients in the development of immune-related adverse events (irAEs) associated with immunotherapy treatment. The evaluation of the differences in terms of irAEs incidence concerning biological aspects will be integrated by the exploration of their gender dimension.</p>", 
    "language": "eng", 
    "title": "G-DEFINER  CRFs", 
    "license": {
      "id": "CC-BY-4.0"
    }, 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "4142786"
          }, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "4142787"
          }
        }
      ]
    }, 
    "grants": [
      {
        "code": "741874", 
        "links": {
          "self": "https://zenodo.org/api/grants/10.13039/501100000780::741874"
        }, 
        "title": "ERA-NET Cofund Promoting Gender Equality in H2020 and the ERA", 
        "acronym": "GENDER NET Plus", 
        "program": "H2020", 
        "funder": {
          "doi": "10.13039/501100000780", 
          "acronyms": [], 
          "name": "European Commission", 
          "links": {
            "self": "https://zenodo.org/api/funders/10.13039/501100000780"
          }
        }
      }
    ], 
    "keywords": [
      "Clinical Oncology, Immunotherapy,  Sex, Gender, Biology, Biostatistics. Bioinformatics"
    ], 
    "publication_date": "2020-10-27", 
    "creators": [
      {
        "affiliation": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy", 
        "name": "Miceli, Rosalba"
      }
    ], 
    "access_right": "open", 
    "resource_type": {
      "subtype": "deliverable", 
      "type": "publication", 
      "title": "Project deliverable"
    }, 
    "related_identifiers": [
      {
        "scheme": "doi", 
        "identifier": "10.5281/zenodo.4142786", 
        "relation": "isVersionOf"
      }
    ]
  }
}